Article
PGK1, a promising biomarker and therapeutic target for patients with acute myeloid leukemia who are susceptible to disease relapse
2020-07-14
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Glycolysis, a multi-step enzymatic reaction, is considered to be the root of cancer development and progression. The aim of this study is to figure out the glycolytic enzyme, phosphoglycerate kinase 1 (PGK1) whether participate in the progression of acute myeloid leukemia (AML) and its possible mechanisms. <bold>Methods</bold>: Four datasets (GSE106096, GSE75086...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a118cff0-8daa-5403-9255-62f354d6e2c4
- DOI
- 10.21203/rs.3.rs-41160/v1
